{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:45:28Z","timestamp":1768409128671,"version":"3.49.0"},"reference-count":35,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.206047","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T19:51:42Z","timestamp":1723319502000},"source":"Crossref","is-referenced-by-count":1,"title":["Solamargine acts as an antiviral by interacting to MZF1 and targeting the core promoter of the hepatitis B virus gene"],"prefix":"10.18632","author":[{"given":"Wenwen","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Zhengzhou University People\u2019s Hospital, Henan Provincial People\u2019s Hospital, Zhengzhou, Henan 450003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Master of Chinese medicine (studies and applications of internal Chinese medicines), Hong Kong Baptist University, Kowloon Tong, Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingli","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Zhengzhou University People\u2019s Hospital, Henan Provincial People\u2019s Hospital, Zhengzhou, Henan 450003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Lu","sequence":"additional","affiliation":[{"name":"Xinxiang Medical University, Clinical Medicine College, Xinxiang, Henan 453000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital Affiliated of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan 450003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Zhengzhou University People\u2019s Hospital, Henan Provincial People\u2019s Hospital, Zhengzhou, Henan 450003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Zhengzhou University People\u2019s Hospital, Henan Provincial People\u2019s Hospital, Zhengzhou, Henan 450003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Zhengzhou University People\u2019s Hospital, Henan Provincial People\u2019s Hospital, Zhengzhou, Henan 450003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suofeng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Zhengzhou University People\u2019s Hospital, Henan Provincial People\u2019s Hospital, Zhengzhou, Henan 450003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2024,8,10]]},"reference":[{"key":"1","unstructured":"Charting a new frontier in chronic hepatitis B research to improve lives worldwide. 2023. https:\/\/www.nature.com\/articles\/d42473-022-00044-x."},{"key":"2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12879-019-4428-y","article-title":"Hepatitis B infection in the general population of China: a systematic review and meta-analysis.","volume":"1","author":"Wu","year":"2019","journal-title":"BMC Infect Dis"},{"key":"3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1586\/17474124.2016.1145547","article-title":"Hepatitis B: treatment choice and monitoring for response and resistance.","volume":"1","author":"Yuen","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"4","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jhep.2016.01.027","article-title":"Overview of hepatitis B viral replication and genetic variability.","volume":"6","author":"Revill","year":"2016","journal-title":"J Hepatol"},{"key":"5","doi-asserted-by":"publisher","first-page":"104761","DOI":"10.1016\/j.antiviral.2020.104761","article-title":"SOX9 represses hepatitis B virus replication through binding to HBV EnhII\/Cp and inhibiting the promoter activity.","volume":"17","author":"Wu","year":"2020","journal-title":"Antiviral Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"36741","DOI":"10.1038\/srep36741","article-title":"LUC7L3\/CROP inhibits replication of hepatitis B virus via suppressing enhancer II\/basal core promoter activity.","volume":"6","author":"Suzuki","year":"2016","journal-title":"Sci Rep"},{"key":"7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/14728222.2021.1915990","article-title":"Hepatitis B virus: promising drug targets and therapeutic implications.","volume":"2","author":"Arbuthnot","year":"2021","journal-title":"Expert Opin Ther Targets"},{"key":"8","doi-asserted-by":"publisher","first-page":"837115","DOI":"10.3389\/fphar.2022.837115","article-title":"Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity.","volume":"1","author":"Tan","year":"2022","journal-title":"Front Pharmacol"},{"key":"9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/diseases6020027","article-title":"Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure.","volume":"6","author":"DiMarino","year":"2018","journal-title":"Diseases"},{"key":"10","doi-asserted-by":"publisher","first-page":"3972390","DOI":"10.1155\/2020\/3972390","article-title":"Natural Products: Review for Their Effects of Anti-HBV.","volume":"202","author":"Kang","year":"2020","journal-title":"Biomed Res Int"},{"key":"11","doi-asserted-by":"publisher","first-page":"114473","DOI":"10.1016\/j.jep.2021.114473","article-title":"Pharmacological validation of Solanum mammosum L. as an anti-infective agent: Role of solamargine.","volume":"28","author":"Haddad","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"12","doi-asserted-by":"publisher","first-page":"979451","DOI":"10.3389\/fphar.2022.979451","article-title":"Anticancer activity of glycoalkaloids from Solanum plants: A review.","volume":"1","author":"oci\u0144ska","year":"2022","journal-title":"Front Pharmacol"},{"key":"13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/v12020160","article-title":"Host Transcription Factors in Hepatitis B Virus RNA Synthesis.","volume":"1","author":"Patel","year":"2020","journal-title":"Viruses"},{"key":"14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3760\/cma.j.issn.1007-3418.2019.08.003","article-title":"[The expert consensus on clinical cure (functional cure) of chronic hepatitis B].","volume":"2","author":"Chinese Society of Infectious Disease Chinese Society of Hepatology, and Chinese Medical Association","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"15","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jhep.2016.02.009","article-title":"Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.","volume":"6","author":"Protzer","year":"2016","journal-title":"J Hepatol"},{"key":"16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/apt.13694","article-title":"Review article: novel therapies for hepatitis B virus cure - advances and perspectives.","volume":"4","author":"Kao","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/hep.32314","article-title":"Getting to HBV cure: The promising paths forward.","volume":"7","author":"Janssen","year":"2022","journal-title":"Hepatology"},{"key":"18","doi-asserted-by":"publisher","first-page":"104824","DOI":"10.1016\/j.antiviral.2020.104824","article-title":"Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.","volume":"18","author":"Guo","year":"2020","journal-title":"Antiviral Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/liv.14851","article-title":"HBV 2021: New therapeutic strategies against an old foe.","volume":"4","author":"Zoulim","year":"2021","journal-title":"Liver Int"},{"key":"20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/ijms22010213","article-title":"Hepatitis B Virus Cure: Targets and Future Therapies.","volume":"2","author":"Ahn","year":"2020","journal-title":"Int J Mol Sci"},{"key":"21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1021\/acsinfecdis.8b00081","article-title":"Virological Basis for the Cure of Chronic Hepatitis B.","volume":"5","author":"Guo","year":"2019","journal-title":"ACS Infect Dis"},{"key":"22","doi-asserted-by":"publisher","first-page":"114034","DOI":"10.1016\/j.jep.2021.114034","article-title":"Anti-tumor effects of Solanum nigrum L. extraction on C6 high-grade glioma.","volume":"27","author":"Li","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"23","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s11010-022-04654-3","article-title":"Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate.","volume":"47","author":"Dhobi","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-022-01248-w","article-title":"Solamargine induces hepatocellular carcinoma cell apoptosis and autophagy via inhibiting LIF\/miR-192-5p\/CYR61\/Akt signaling pathways and eliciting immunostimulatory tumor microenvironment.","volume":"1","author":"Yu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3892\/ijo.2019.4744","article-title":"Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway.","volume":"5","author":"Ji","year":"2019","journal-title":"Int J Oncol"},{"key":"26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/jcmm.12958","article-title":"Targeting EP4 downstream c-Jun through ERK1\/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells.","volume":"2","author":"Hann","year":"2017","journal-title":"J Cell Mol Med"},{"key":"27","doi-asserted-by":"publisher","first-page":"9055954","DOI":"10.1155\/2022\/9055954","article-title":"Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling.","volume":"202","author":"Zhang","year":"2022","journal-title":"J Oncol"},{"key":"28","doi-asserted-by":"publisher","first-page":"7634754","DOI":"10.1155\/2022\/7634754","article-title":"Solamargine Alleviates Proliferation and Metastasis of Cervical Cancer Cells by Blocking the CXCL3-Mediated Erk Signaling Pathway.","volume":"202","author":"Wang","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ptr.6555","article-title":"The regulation and interaction of colon cancer-associated transcript-1 and miR7-5p contribute to the inhibition of SP1 expression by solamargine in human nasopharyngeal carcinoma cells.","volume":"3","author":"Hann","year":"2020","journal-title":"Phytother Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"e0054622","DOI":"10.1128\/jvi.00546-22","article-title":"Forkhead O Transcription Factor 4 Restricts HBV Covalently Closed Circular DNA Transcription and HBV Replication through Genetic Downregulation of Hepatocyte Nuclear Factor 4 Alpha and Epigenetic Suppression of Covalently Closed Circular DNA via Interacting with Promyelocytic Leukemia Protein.","volume":"9","author":"Gao","year":"2022","journal-title":"J Virol"},{"key":"31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.5114\/aoms.2018.79712","article-title":"Establishment of stable cell lines in which the HBV genome replicates episomally for evaluation of antivirals.","volume":"1","author":"Li","year":"2018","journal-title":"Arch Med Sci"},{"key":"32","doi-asserted-by":"publisher","first-page":"12874","DOI":"10.1038\/s41598-017-12497-y","article-title":"Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression.","volume":"7","author":"Suzuki","year":"2017","journal-title":"Sci Rep"},{"key":"33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1046\/j.1365-2893.1999.00189.x","article-title":"The core promoter of hepatitis B virus.","volume":"6","author":"Kew","year":"1999","journal-title":"J Viral Hepat"},{"key":"34","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3892\/ijmm.2018.3396","article-title":"Engineered zinc-finger transcription factors inhibit the replication and transcription of HBV in vitro and in vivo.","volume":"4","author":"Li","year":"2018","journal-title":"Int J Mol Med"},{"key":"35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/v13030524","article-title":"Liver-Derived Cell Transfection Model Efficacy for HBV Genotype B Replication\/Transcription Is Determined by Complex Host Transcription Factor Network.","volume":"1","author":"Lee","year":"2021","journal-title":"Viruses"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T19:51:46Z","timestamp":1723319506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,10]]},"references-count":35,"alternative-id":["206047"],"URL":"https:\/\/doi.org\/10.18632\/aging.206047","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,10]]}}}